Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Valeant Pharmaceuticals International

4107485Q:US

Acquired

Valeant Pharmaceuticals International (4107485Q:US) was acquired by VRX:CN


Company Profile

Valeant Pharmaceuticals International operates as a research-based, specialty pharmaceutical company. The Company discovers, develops, manufactures, and markets a range of pharmaceutical products as well as focusing on products in the areas of infectious disease, neurology, and dermatology. Valeant Pharmaceuticals markets its products worldwide.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...
Advertisement
sec ||= nil